COVPRIG robustly predicts the overall survival of IDH wild-type glioblastoma and highlights METTL1+ neural-progenitor-like tumor cell in driving unfavorable outcome
Abstract Background Accurately predicting the outcome of isocitrate dehydrogenase (IDH) wild-type glioblastoma (GBM) remains hitherto challenging. This study aims to Construct and Validate a Robust Prognostic Model for IDH wild-type GBM (COVPRIG) for the prediction of overall survival using a novel...
Main Authors: | Hang Ji, Fang Wang, Zhihui Liu, Yue Li, Haogeng Sun, Anqi Xiao, Huanxin Zhang, Chao You, Shaoshan Hu, Yi Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-04382-2 |
Similar Items
-
Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse Gliomas
by: Kanish Mirchia, et al.
Published: (2020-07-01) -
Deep Learning Can Differentiate IDH-Mutant from IDH-Wild GBM
by: Luca Pasquini, et al.
Published: (2021-04-01) -
Prognostic analysis and nomogram construction for older patients with IDH-wild-type glioblastoma
by: Wenjun Cao, et al.
Published: (2023-07-01) -
Molecular and clinical characteristics of IDH mutations in Chinese NSCLC patients and potential treatment strategies
by: Shuchen Chen, et al.
Published: (2022-11-01) -
Clinical Significance and Systematic Expression Analysis of the Thyroid Receptor Interacting Protein 13 (TRIP13) as Human Gliomas Biomarker
by: Ssu-Han Chen, et al.
Published: (2021-05-01)